You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 1, January 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Caution Urged in Treating 'Steroid-Dependent Anosmia'

APRIL E. SCOTT, MD
Farmington, Conn

Arch Otolaryngol Head Neck Surg. 1989;115(1):109-110.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—Anosmia secondary to an active process in the nose and/or sinuses is the most treatable form of smell dysfunction. At the University of Connecticut's (Farmington) Taste and Smell Center, management of these disorders is frequently frustrated by the chronicity of these problems. Surgery or limited courses of medications fail to yield enduring positive results. Jafek and colleagues1 have provided a report of two patients with anosmia, nasal polyposis, and pansinusitis. Surgery afforded only short-term improvement in olfactory function. Various medical therapies instituted during periods of anosmia were ineffective with the exception of temporary improvement with oral corticosteroid therapy in one case. When low-dose, oral corticosteroid therapy was instituted after surgery, however, the postoperative improvement in smell functioning was maintained even one and two years postoperatively. Jafek et al have classified these patients as having "steroid-dependent anosmia." They posed the following question: "Why was the combined treatment . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.